iBio (IBIO) Common Equity (2011 - 2026)
iBio's Common Equity came in at $85.71 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 476.0% from $14.88 million a year earlier and up 10.5% from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Common Equity (2011 - 2026) Analysis & Trends
Going back to fiscal Q4 2011, iBio's Common Equity data covers 61 quarters.
- Common Equity carries a five-year compound annual growth rate of -4.6% (FY2021 to FY2026).
- Going back by fiscal year, Common Equity was $14.88 million in FY2025 (-30.2%), $21.32 million in FY2024 (+38.6%), $15.38 million in FY2023 (-75.8%) and $63.49 million in FY2022 (-41.5%).
- The fiscal Q4 2026 figure represents the highest quarterly Common Equity since fiscal Q2 2022.
- Year-over-year, Common Equity has increased for four consecutive quarters, with growth averaging 197.6% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in fiscal Q3 2026 (growth of 581.3%), and the weakest in fiscal Q2 2023 (a decline of 79.2%).
- Business Quant data shows IBIO's Common Equity at $77.54 million (Q3 2026), $56.56 million (Q2 2026) and $56.04 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | iBio | 121.75 Mn | 121.75 Mn | - | 85.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 85.71 Mn |
| Mar 31, 2026 | 77.54 Mn |
| Dec 31, 2025 | 56.56 Mn |
| Sep 30, 2025 | 56.04 Mn |
| Jun 30, 2025 | 14.88 Mn |
| Mar 31, 2025 | 11.38 Mn |
| Dec 31, 2024 | 13.90 Mn |
| Sep 30, 2024 | 17.75 Mn |
| Jun 30, 2024 | 21.32 Mn |
| Mar 31, 2024 | 24.86 Mn |
| Dec 31, 2023 | 9.20 Mn |
| Sep 30, 2023 | 13.21 Mn |
| Jun 30, 2023 | 15.38 Mn |
| Mar 31, 2023 | 17.39 Mn |
| Dec 31, 2022 | 18.82 Mn |
| Sep 30, 2022 | 48.37 Mn |
| Jun 30, 2022 | 63.49 Mn |
| Mar 31, 2022 | 79.38 Mn |
| Dec 31, 2021 | 90.60 Mn |
| Sep 30, 2021 | 100.53 Mn |
API Access
iBio Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();